当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析 - 现金流量表

华森制药

(002907)

  

流通市值:45.97亿  总市值:57.17亿
流通股本:3.36亿   总股本:4.18亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金196,111,535.46813,988,252.62614,186,041.27410,213,008.49
  收到的税费返还123,741.341,438,103.711,438,103.711,438,103.71
  收到其他与经营活动有关的现金3,801,926.9724,521,350.8322,545,578.8512,246,976.57
  经营活动现金流入小计200,037,203.77839,947,707.16638,169,723.83423,898,088.77
  购买商品、接受劳务支付的现金50,129,944.99279,456,370.8218,495,293.33130,299,225.37
  支付给职工以及为职工支付的现金51,339,112.42161,655,482.07121,601,818.1281,835,620.83
  支付的各项税费22,713,914.78105,131,206.1480,968,255.4157,981,836.71
  支付其他与经营活动有关的现金51,377,682.06231,464,825.68192,311,937.1126,255,067.22
  经营活动现金流出小计175,560,654.25777,707,884.69613,377,303.96396,371,750.13
  经营活动产生的现金流量净额24,476,549.5262,239,822.4724,792,419.8727,526,338.64
二、投资活动产生的现金流量:
  收回投资收到的现金200,000,000644,284,821.33550,000,000230,000,000
  取得投资收益收到的现金2,053,938.735,788,519.75,349,047.491,781,185.5
  处置固定资产、无形资产和其他长期资产收回的现金净额-6,559,502.26,500,000-
  收到的其他与投资活动有关的现金-5,308,473.5--
  投资活动现金流入小计202,053,938.73661,941,316.73561,849,047.49231,781,185.5
  购建固定资产、无形资产和其他长期资产支付的现金6,974,108.8714,557,492.368,892,142.464,679,728.18
  投资支付的现金197,471,700840,000,000690,000,000400,000,000
  取得子公司及其他营业单位支付的现金---447,333.24-447,333.24
  支付其他与投资活动有关的现金-12,000,000--
  投资活动现金流出小计204,445,808.87866,557,492.36698,444,809.22404,232,394.94
  投资活动产生的现金流量净额-2,391,870.14-204,616,175.63-136,595,761.73-172,451,209.44
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-35,495,685.2935,495,686.720,879,815.7
  支付其他与筹资活动有关的现金240,848.554,247,304.756,105,250.176,063,274.17
  筹资活动现金流出小计240,848.5539,742,990.0441,600,936.8726,943,089.87
  筹资活动产生的现金流量净额-240,848.55-39,742,990.04-41,600,936.87-26,943,089.87
四、汇率变动对现金及现金等价物的影响-65,485.02-95,317.35-179,691.37-131,580.48
五、现金及现金等价物净增加额21,778,345.81-182,214,660.55-153,583,970.1-171,999,541.15
  加:期初现金及现金等价物余额274,337,234.85456,551,895.4456,551,895.4456,551,895.4
  期末现金及现金等价物余额296,115,580.66274,337,234.85302,967,925.3284,552,354.25
补充资料:
  净利润-55,210,478.38-52,286,443.02
  资产减值准备-1,944,374.59-240,732.9
  固定资产和投资性房地产折旧-66,643,587.07-33,639,802.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-66,643,587.07-33,639,802.44
  无形资产摊销-20,871,579.12-9,911,181.76
  长期待摊费用摊销-3,282,055.23-1,432,777.79
  处置固定资产、无形资产和其他长期资产的损失--10,245,671.69--
  固定资产报废损失-442,810-234,733.67
  公允价值变动损失--1,417,619.96--755,500.26
  财务费用--4,291,235.47-51,406.84
  投资损失--8,276,482.1--15,570,992.36
  递延所得税--2,735,652.69-14,316,058.55
  其中:递延所得税资产减少--2,464,061.82-2,079,830.95
    递延所得税负债增加--271,590.87-12,236,227.6
  存货的减少-1,411,880.96-19,379,383.69
  经营性应收项目的减少--79,842,265.73--76,328,150.38
  经营性应付项目的增加-18,667,461.39--11,382,777.22
  现金的期末余额-274,337,234.85-284,552,354.25
  减:现金的期初余额-456,551,895.4-456,551,895.4
  现金及现金等价物的净增加额--182,214,660.55--171,999,541.15
公告日期2026-04-302026-04-242025-10-292025-08-22
审计意见(境内)标准无保留意见
TOP↑